Public Declarations

As the leading European medical society focusing on allergy, EAACI has a key role to play in the formulation of health and research policies at the European level. EAACI activities focus on improving allergy care, fostering allergy research and help strengthen Allergology as a medical specialty.

By being present in Brussels, EAACI aims to establish allergy ambassadors among EU Parliament members and to have consistent interaction with different EU Institutions, to promote allergy awareness.
The public health risk posed by allergy has been largely underestimated, the underlying common fallacy being that it is just a mild disease. Yet, as you are well aware, allergy is a public health concern of pandemic proportions, affecting today more than 150 million people in Europe and wreaking far-reaching damage in terms of both human suffering and economic burden.

Although important steps have been taken at the EU level by integrating allergy in the EU’s public health agenda, lack of concerted action and lack of realization on both the true risks of allergic diseases and the preventive treatments that can stop their progression still hold sway. As a result, the quality of life of millions of Europeans and their families is impaired while the financial burden of health care and loss in productivity is continuously growing.

On the occasion of the centenary of the first scientific publication on allergy’s signature treatment, ‘allergen-specific immunotherapy’ (1911-2011), EAACI prepared a pivotal document: A ‘European Declaration on Immunotherapy’, which was co-signed by EFA, the European Federation of Allergy and Airway Diseases Patient Associations, and GA2LEN, an EU-supported Network of Excellence. Its purpose was to raise awareness of the detrimental impact of allergy on Europe and to suggest specific actions designed to face this growing problem effectively.

The Declaration was launched 13 June 2011, on the occasion of the EAACI General Assembly during the 30th EAACI Congress in Istanbul.

  • Immunotherapy Declaration in English
  • Immunotherapy Declaration in Dutch
  • Immunotherapy Declaration in Greek
  • Immunotherapy Declaration in Italian
  • Immunotherapy Declaration in Lithuanian
  • Immunotherapy Declaration in Polish
  • Immunotherapy Declaration in Portuguese
  • Immunotherapy Declaration in Russian
  • Immunotherapy Declaration in Spanish
  • Immunotherapy Declaration in Turkish
Last updated 04 November 2014
Privacy Policy - disclaimer

EAACI recently updated its privacy policy and would like to highlight some key bits of information with you.

  • EAACI does not distribute, share or sell your information;
  • For technical and administrative purposes some information that can be used to identify you may be forwarded to third parties. For example, to process your registration for the EAACI Annual Congress and other EAACI events;
  • The Academy may also send you e-mail messages with news from the society. If you would like to no longer receive them, you can unsubscribe at any time by using the unsubscribe link in any of our communications;
  • You may also update your preferences or your profile information at any time by contacting us.

To continue please confirm that you agree with our updated privacy policy.

Thank you!

You have successfully agreed the new privacy policy – disclaimer.

Thank you!

You disagreed with the new privacy policy – disclaimer and your feedback will be reviewed as soon as possible.

Agree & Continue
Disagree
Send feedback
Cancel